INO
INOVIO PHARMACEUTICALS, INC.
PDUFA
Confirmed
INO-3107
Recurrent Respiratory Papillomatosis (RRP)
T-minus 70 days
Oct 30, 2026
SEC 8-K
verified 2mo ago
Countdown card β